Headline News

More than half of the top videos on TikTok about conception strategies without treatment were not backed by science, with most created by nonprofessionals and content creators for profit, according to a research letter.

Although best corrected visual acuity was the only visual function test ready for immediate use in a diabetic retinal disease staging system, others showed promise or potential, according to a report published in Ophthalmology Science.

ORLANDO — A lifestyle medicine toolkit for cancer risk reduction and survivorship “received significant engagement” in part due to its comprehensiveness and feasibility, according to a speaker at the Lifestyle Medicine Conference.

PHILADELPHIA — Pharmacologic therapy for alcohol use disorder may be an “underutilized treatment modality,” especially in patients with related liver disease, according to research presented at the ACG Annual Scientific Meeting.

Weight loss from weekly semaglutide injections accompanied significant reductions in pain related to knee osteoarthritis, according to data published in The New England Journal of Medicine.

The AAP released updated recommendations for preventing injuries and fostering a safe environment in cheer, a sport that an estimated 3.5 million youth participate in in the United States.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Paulo-Eduardo Stanga, MD, speaks in favor of treating vitreous floaters and opacities.

WISDOM, a research study comparing annual mammography with a personalized approach to screening based on individual risk factors, is currently underway and enrolling women in the U.S. aged 30 to 74 years without a history of breast cancer.

IgGenix announced the first patient dosed with IGNX001, a monoclonal antibody-based therapeutic for peanut allergy.

The FDA has approved an adeno-associated virus vector-based gene therapy to treat both adult and pediatric patients with aromatic L-amino acid decarboxylase deficiency.